![]() |
Volumn 88, Issue 48, 2010, Pages 25-27
|
Untangling biosimilars: FDA faces conflicting views on how to develop drug approval pathway
a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
|
EID: 78649786440
PISSN: 00092347
EISSN: 1520605X
Source Type: Trade Journal
DOI: 10.1021/cen-v088n048.p025 Document Type: Article |
Times cited : (13)
|
References (0)
|